Winter 2024
10 RMS Update
A collection of recent exciting Royal Microscopical Society news stories.
SPOT LIGHT
12 Comprehensive solutions for tablet and capsule manufacturing
Discover how Natoli Engineering empowers the pharmaceutical industry with innovative equipment, expert training, and unparalleled customer support and expertise
14 Powering pharma innovation: building a workforce for the future
What are some leadership and human resource strategies critical to success in the pharma CDMO sector, including best practices, emerging trends and challenges in managing talent within a highly competitive and evolving industry?
18 Why the pharmaceutical industry is embracing continuous manufacturing Batch manufacturing has been the standard in the pharma industry, however continuous manufacturing is now proving to be the better choice for efficiency, cost saving and reducing waste. How can new technologies improve this method further?
22 Advancing cell line development: how next-gen innovation meets industry needs
Cell line development is integral to research and biotherapeutic production, and so ensuring this process is as robust as possible through next-generation technology is in the industry’s best interests.
26 Harnessing spatial biology in drug discovery and development: navigating opportunities and challenges
How is current spatial biology being utilised in drug discovery and development for complex disease treatments, and how can it be improved?
30 The future of generative AI and automation in drug discovery
How is generative AI being utilised in drug discovery to improve processes and secure higher-quality drugs?
33 Transforming pharma companies for customer-centricity
How can digital transformations be implemented and utilised effectively to ensure customer-centricity in the pharma sector?
36 Cloud-based computing: driving next-generation drug development
Cloud-based tools like process analytical technology can be used to improve pharma manufacturing processes, speeding up quality assurance and time-to-market in a cost-effective manner.
38 Harnessing AI in life sciences clinical R&D: use cases and benefits across eight key functions
The use of artificial intelligence is becoming increasingly common in life sciences R&D. In what areas can it be utilised in the most helpful manner?
42 Rapid microbiological monitoring: transforming environmental monitoring in pharmaceutical manufacturing
How can highly specialised monitoring be achieved in a fast, cost-effective manner?
46 One cannot leverage AI without a connected laboratory
A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities.
6 Editorial Desk
The first flurries of snow have started peppering the ground, but pharma tech innovation is as fiery-hot as ever!
8 Product News
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing.
50 Events
A collation of the top pharma events for the final month of 2024 and the start of 2025!
EXECUTIVE DIRECTOR
PMGroup Worldwide Ltd
Karl Equi
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson
DEPUTY EDITORS
Charlie Blackie-Kelly
James Spargo
EDITORIAL ASSISTANTS
Betsy Goodfellow
Daria da Silva
SALES
Simon Caplan
Louise Wilson-English
DESIGN
Peter May
FRONT COVER
Shutterstock
DIGITAL EDITION
IPT Online
www.iptonline.com
CONTACT US
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
PRINTING
Hardings Print Solutions
www.hps-ltd.org.uk
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2023 Samedan Ltd
Pharmaceutical Publishers